Takeda plans to relocate 100 researchers to US — 3 insights

Takeda Pharmaceuticals is relocating approximately 100 researchers to Boston during fiscal year 2017, Nikkei Asian Review reports.

Advertisement

Here’s what you should know:

1. The company is relocating its researchers to develop new talent in pursuit of additional revenue sources.

2. Takeda will select the researchers from a candidate pool of its current researchers.

3. Takeda has not announced how long the researchers will be in the U.S.

More articles on gastroenterology: 
Berkshire Health Systems adds gastroenterologist Dr. Jacques Reichling — 3 key notes
GI leader to know: Dr. Mark Eisner of Florida Medical Clinic
OrphoMed secures $39M for IBS-D drug development — 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.